$ Value
—
Shares
319,331
Price
—
Filed
Dec 12
Insider
Name
Aslan Fred
Title
President and CEO
CIK
0001909362
Roles
Transaction Details
Transaction Date
2025-12-12
Code
D
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
—
Footnotes
Represents restricted stock units award granted under the Issuer's 2024 Equity Incentive Plan ("RSUs"). | On December 12, 2025, the Issuer cancelled, pursuant to an option exchange, the options listed in Table II. In exchange for the cancelled options, the Reporting Person received the RSUs reported in Table I. | 25% of the shares vested on February 22, 2022, and the remaining shares vest in 36 equal monthly installments thereafter. | 25% of the shares vest on January 1, 2022, and the remaining shares vest in 36 equal monthly installments thereafter. | Vesting is monthly over a 48-month period starting January 1, 2024 in equal monthly amounts. | 25% of the shares will vest on July 19, 2025, and the remaining shares vest in 36 equal monthly installments thereafter.
Filing Info
Aslan Fred's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-15 | ARTV | A | $0 |
| 2026-02-15 | ARTV | F | $58K |
| 2025-12-15 | ARTV | ▼ | $19K |
| 2025-12-12 | ARTV | A | $0 |
| 2025-12-12 | ARTV | D | — |
| 2025-12-12 | ARTV | D | — |
| 2025-12-12 | ARTV | D | — |
| 2025-12-12 | ARTV | D | — |
| 2025-12-12 | ARTV | D | — |
| 2025-12-12 | ARTV | D | — |
Other Insiders at ARTV (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Bush Jennifer
COO, CLO, Secy, Compliance Off
|
— | — | 2026-02-15 |
|
Horan Christopher
Chief Tech Operations Officer
|
— | — | 2026-02-15 |
| Sorg Elaine K. | — | — | 2026-02-18 |
|
Aslan Fred
President and CEO
|
— | — | 2026-02-15 |
|
Raymon Heather
SVP, Research and Development
|
— | — | 2026-02-15 |
|
Banerjee Subhashis
Chief Medical Officer
|
— | — | 2026-02-15 |